You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
藍曉科技(300487.SZ):公司多肽固相合成載體銷售增長明顯
格隆匯 01-04 20:01

格隆匯1月4日丨藍曉科技(300487.SZ)在投資者關係活動上表示,受益於全球範圍內GLP-1類多肽藥物銷售大幅增加,公司多肽固相合成載體銷售增長明顯。固相合成載體是公司成熟產品,公司已連續多年向下遊多肽藥企銷售。在GLP-1藥物爆發前,多肽固相合成載體作為細分領域,該市場競爭對手較少。此外,經過多年與藥企合作,公司該品系產品不斷優化,形成了豐富的技術積累。在該領域,公司具有Seplife2-CTC固相合成載體和Sieber樹脂、Rink、Wang等多款產品,在產品品質、工藝穩定性、與客户粘性等方面具有一定的先發優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account